Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies, a biopharmaceutical company focused on CNS disorders, announced that CEO Sharon Mates will present at the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, at 11:00 am ET. The presentation will be accessible live and archived on the company's website under the Investor Relations section. The company's innovative treatments are based on Nobel prize-winning research aimed at understanding cell interactions. For more details, visit www.intracellulartherapies.com.

NEW YORK, April 05, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 11:00 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When is Sharon Mates presenting at the Needham Virtual Healthcare Conference?

Sharon Mates is scheduled to present on April 12, 2022, at 11:00 am ET.

Where can I watch the Intra-Cellular Therapies presentation?

The presentation can be accessed live and archived under 'Events & Presentations' in the Investor Relations section of the company's website.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

What recent announcement did Intra-Cellular Therapies make?

The company announced the participation of CEO Sharon Mates in the Needham Virtual Healthcare Conference.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.